Search filters

List of works by Olga Salamero

Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease

scientific article published on 08 June 2020

Adverse impact of IDH1 and IDH2 mutations in primary AML: Experience of the Spanish CETLAM group

article

Anemia associated with impaired erythropoietin secretion after allogeneic stem cell transplantation: incidence, risk factors, and response to treatment

scientific article published in August 2008

Autologous stem cell transplantation for patients with active Hodgkin's lymphoma: Long-term outcome of 61 patients from a single institution

scientific article published on 01 October 2007

Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML.

scientific article published on 15 April 2013

Bortezomib-induced rhabdomyolysis in multiple myeloma

scientific article

Bortezomib: an effective agent in extramedullary disease in multiple myeloma

scientific article published on 9 March 2006

Complex Measurements May Be Required to Establish the Prognostic Impact of Immunophenotypic Markers in AML

scientific article published on 01 September 2015

Differential gene expression profile associated to apoptosis induced by dexamethasone in CLL cells according to IGHV/ZAP-70 status.

scientific article

Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect

scientific article published on 24 December 2016

Elacytarabine in relapsed/refractory acute myeloid leukaemia: an evaluation of clinical efficacy, pharmacokinetics, cardiac safety and effects on lipid profile.

scientific article published on 25 December 2013

Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy

scientific article published in February 2013

Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis

scientific article published on 11 July 2020

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia

scientific article published on 14 October 2020

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

article

Herpes simplex and Epstein-Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine

scientific article published in November 2006

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

scientific article published on 28 May 2013

Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia.

scientific article published on 25 April 2015

Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia

scientific article published on 01 October 2013

Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis.

scientific article published on 13 February 2015

Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry

scientific article published on 09 May 2019

Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.

scientific article published on 24 August 2009

The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.

scientific article

Paulina is supported by:

About Paulina

Help